Belgian tech firm Biotalys plans listing on Euronext Brussels

Today, Belgian agri-tech company Biotalys announced its plans to list on Euronext Brussels in the coming weeks. This way, the firm intends to entice investors with its biological alternatives to chemical pesticides. The company was founded in 2013; it is a spin-off from the Flanders Institute for Biotechnology and the agricultural counterpart to biopharmaceutical firm Ablynx -also from Belgium- which Sanofi bought in 2018 for €3.9 billion.

Both use llama antibodies, which are smaller and easier to manipulate than human equivalents. Biotalys extracts proteins for use against fungi, bacteria and insects that attack crops, especially high-value fruit like grapes and strawberries.

Biotalys aims to secure US regulatory approval in mid-2022 for its first product, Evoca. After that, it intends a 2024 launch in the EU, which aims to cut chemical pesticide use by 50% by 2030.

According to¸ the company has seven potential products it intends to launch over the next decade and estimates the market could be worth $4.8 billion as countries shift to greener forms of farming.

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Facebook Twitter LinkedIn Instagram Rss

© 2021

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber